Xin J Qiao1, Hyun Grace Kim1, Danny J J Wang2, Noriko Salamon1, Michael Linetsky1, Ali Sepahdari1, Benjamin M Ellingson1, Whitney B Pope3. 1. Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. 2. Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. 3. Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. Electronic address: wpope@mednet.ucla.edu.
Abstract
PURPOSE: Differentiating WHO grade I-III of meningioma by non-invasive imaging is challenging. This study investigated the potential of MR arterial spin labeling (ASL) to establish tumor grade in meningioma patients. MATERIAL AND METHODS: Pseudo-continuous ASL with 3D background suppressed gradient and spin echo (GRASE) was acquired on 54 patients with newly diagnosed or recurrent intracranial meningioma. Perfusion patterns characterized in CBF color maps were independently evaluated by three neuroradiologists blinded to patient history, and correlated with tumor grade from histo-pathological review. RESULTS: Three perfusion patterns could be discerned by visual evaluation of CBF maps. Pattern 1 consisted of homogeneous hyper-perfusion of the entire tumor; pattern 2 demonstrated heterogeneous hyper-perfusion; pattern 3 showed no substantial hyper-perfusion. Evaluation of the perfusion patterns was highly concordant among the three readers (Kendall W=0.9458, P<0.0001). Pattern 1 was associated with WHO Grade I meningioma of (P<0.0001). Patterns 2 and 3 were predictive of WHO Grade II and III meningioma (P<0.0001), with an odds ratio (OR, versus pattern 1) of 49.6 (P<0.01) in a univariate analysis, and an OR of 186.4 (P<0.01) in a multivariate analysis. CONCLUSION: Qualitative evaluation of ASL CBF maps can help differentiate benign (WHO Grade I) from higher grade (WHO Grade II and III) intracranial meningiomas, potentially impacting therapeutic strategy.
PURPOSE: Differentiating WHO grade I-III of meningioma by non-invasive imaging is challenging. This study investigated the potential of MR arterial spin labeling (ASL) to establish tumor grade in meningiomapatients. MATERIAL AND METHODS: Pseudo-continuous ASL with 3D background suppressed gradient and spin echo (GRASE) was acquired on 54 patients with newly diagnosed or recurrent intracranial meningioma. Perfusion patterns characterized in CBF color maps were independently evaluated by three neuroradiologists blinded to patient history, and correlated with tumor grade from histo-pathological review. RESULTS: Three perfusion patterns could be discerned by visual evaluation of CBF maps. Pattern 1 consisted of homogeneous hyper-perfusion of the entire tumor; pattern 2 demonstrated heterogeneous hyper-perfusion; pattern 3 showed no substantial hyper-perfusion. Evaluation of the perfusion patterns was highly concordant among the three readers (Kendall W=0.9458, P<0.0001). Pattern 1 was associated with WHO Grade I meningioma of (P<0.0001). Patterns 2 and 3 were predictive of WHO Grade II and III meningioma (P<0.0001), with an odds ratio (OR, versus pattern 1) of 49.6 (P<0.01) in a univariate analysis, and an OR of 186.4 (P<0.01) in a multivariate analysis. CONCLUSION: Qualitative evaluation of ASL CBF maps can help differentiate benign (WHO Grade I) from higher grade (WHO Grade II and III) intracranial meningiomas, potentially impacting therapeutic strategy.
Authors: H Kimura; H Takeuchi; Y Koshimoto; H Arishima; H Uematsu; Y Kawamura; T Kubota; H Itoh Journal: AJNR Am J Neuroradiol Date: 2006-01 Impact factor: 3.825
Authors: Katerina Deike; Benedikt Wiestler; Markus Graf; Caroline Reimer; Ralf O Floca; Philipp Bäumer; Philipp Kickingereder; Sabine Heiland; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch Journal: J Neurooncol Date: 2015-10-30 Impact factor: 4.130
Authors: Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee Journal: J Neuropathol Exp Neurol Date: 2002-03 Impact factor: 3.685
Authors: Benno Küsters; Robert M W de Waal; Pieter Wesseling; Kiek Verrijp; Cathy Maass; Arend Heerschap; Jelle O Barentsz; Fred Sweep; Dirk J Ruiter; William P J Leenders Journal: Cancer Res Date: 2003-09-01 Impact factor: 12.701
Authors: Eskil Eskilsson; Gro V Rosland; Krishna M Talasila; Stian Knappskog; Olivier Keunen; Andrea Sottoriva; Sarah Foerster; Gergely Solecki; Torfinn Taxt; Radovan Jirik; Sabrina Fritah; Patrick N Harter; Kristjan Välk; Jubayer Al Hossain; Justin V Joseph; Roza Jahedi; Halala S Saed; Sara G Piccirillo; Inma Spiteri; Lina Leiss; Philipp Euskirchen; Grazia Graziani; Thomas Daubon; Morten Lund-Johansen; Per Øyvind Enger; Frank Winkler; Christoph A Ritter; Simone P Niclou; Colin Watts; Rolf Bjerkvig; Hrvoje Miletic Journal: Neuro Oncol Date: 2016-06-10 Impact factor: 12.300
Authors: Danny J J Wang; Jeffry R Alger; Joe X Qiao; Matthias Gunther; Whitney B Pope; Jeffrey L Saver; Noriko Salamon; David S Liebeskind Journal: Neuroimage Clin Date: 2013-07-06 Impact factor: 4.881
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: Shun Zhang; Gloria Chia-Yi Chiang; Jacquelyn Marion Knapp; Christina M Zecca; Diana He; Rohan Ramakrishna; Rajiv S Magge; David J Pisapia; Howard Alan Fine; Apostolos John Tsiouris; Yize Zhao; Linda A Heier; Yi Wang; Ilhami Kovanlikaya Journal: J Neuroradiol Date: 2019-05-25 Impact factor: 3.447
Authors: Raymond Y Huang; Wenya Linda Bi; Brent Griffith; Timothy J Kaufmann; Christian la Fougère; Nils Ole Schmidt; Jöerg C Tonn; Michael A Vogelbaum; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Ian F Dunn Journal: Neuro Oncol Date: 2019-01-14 Impact factor: 12.300
Authors: Norbert Galldiks; Frank Angenstein; Jan-Michael Werner; Elena K Bauer; Robin Gutsche; Gereon R Fink; Karl-Josef Langen; Philipp Lohmann Journal: Brain Pathol Date: 2022-03 Impact factor: 6.508